User profiles for Karel Sonka

Karel Šonka

Department of Neurology, First Faculty of Medicine, Charles University and General …
Verified email at lf1.cuni.cz
Cited by 2647

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

…, D Arnaldi, B Mollenhauer, A Videnovic, K Sonka… - Brain, 2019 - academic.oup.com
Idiopathic REM sleep behaviour disorder (iRBD) is a powerful early sign of Parkinson’s
disease, dementia with Lewy bodies, and multiple system atrophy. This provides an …

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study

…, YE Ju, M Puligheddu, K Sonka… - Annals of …, 2015 - Wiley Online Library
Objective To assess whether risk factors for Parkinson disease and dementia with Lewy
bodies increase rate of defined neurodegenerative disease in idiopathic rapid eye movement (…

PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome

…, W Poewe, I Peglau, P Vodicka, J Vávrová, K Sonka… - Nature …, 2008 - nature.com
We identified association of restless legs syndrome (RLS) with PTPRD at 9p23–24 in 2,458
affected individuals and 4,749 controls from Germany, Austria, Czechia and Canada. Two …

European guideline and expert statements on the management of narcolepsy in adults and children

…, P Reading, J Santamaria, K Sonka… - European journal of …, 2021 - Wiley Online Library
Background and aim Narcolepsy is an uncommon hypothalamic disorder of presumed
autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence‐…

[HTML][HTML] ImmunoChip study implicates antigen presentation to T cells in narcolepsy

…, S Overeem, GJ Lammers, D Kemlink, K Sonka… - PLoS …, 2013 - journals.plos.org
Recent advances in the identification of susceptibility genes and environmental exposures
provide broad support for a post-infectious autoimmune basis for narcolepsy/hypocretin (…

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from …

…, B Frauscher, B Hogl, JF Gagnon, R Postuma, K Sonka… - Sleep medicine, 2013 - Elsevier
Objectives We aimed to provide a consensus statement by the International Rapid Eye
Movement Sleep Behavior Disorder Study Group (IRBD-SG) on devising controlled active …

[HTML][HTML] Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis

…, B Högl, W Poewe, D Kemlink, K Sonka… - The Lancet …, 2017 - thelancet.com
Background Restless legs syndrome is a prevalent chronic neurological disorder with
potentially severe mental and physical health consequences. Clearer understanding of the …

[HTML][HTML] Diagnosis of central disorders of hypersomnolence: a reappraisal by European experts

…, G Plazzi, PJ Reading, J Santamaria, K Sonka… - Sleep medicine …, 2020 - Elsevier
The aim of this European initiative is to facilitate a structured discussion to improve the next
edition of the International Classification of Sleep Disorders (ICSD), particularly the chapter …

[HTML][HTML] Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12. 1

…, I Fietze, J Vávrová, D Kemlink, K Sonka… - PLoS …, 2011 - journals.plos.org
Restless legs syndrome (RLS) is a sensorimotor disorder with an age-dependent prevalence
of up to 10% in the general population above 65 years of age. Affected individuals suffer …

[HTML][HTML] Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder

J Hlavnička, R Čmejla, T Tykalová, K Šonka… - Scientific reports, 2017 - nature.com
For generations, the evaluation of speech abnormalities in neurodegenerative disorders
such as Parkinson’s disease (PD) has been limited to perceptual tests or user-controlled …